On May 15, 2015, the FDA issued a drug safety communication notifying healthcare providers and diabetes patients that type 2 diabetes drugs like Invokana could increase the risk of diabetic ketoacidosis. (DKA). This is a very serious condition in which the blood becomes too acidic.…
The newer-generation anticoagulant Xarelto (rivaroxaban) has ended up in the news lately because of its connection to serious side effects like gastrointestinal bleeding, brain hemorrhaging, blood clots, and stroke. A recent study, however, has now raised additional concerns that Xarelto may be dang
Though Zofran lawsuits have not yet been consolidated into one court, litigation continues to grow. Just in the last few weeks, three more cases were filed in different federal courts, each claiming that Zofran (ondansetron) manufacturers GlaxoSmithKline (GSK) failed to provide adequate warnings abo
On June 22, 2015, Health Canada announced that it was investigating the safety of Invokana (canagliflozin) and other similar medications because of concerns these type 2 diabetes drugs may increase risk of ketoacidosis. Ketoacidosis is a condition in which the pH balance in the blood…
It’s been just over a year since the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all federally filed testosterone lawsuits into one court in the Northern District of Illinois. Today, over 1,800 cases are pending, with plaintiffs bringing claims against the manufacturers of An
The type 2 diabetes drug Invokana (canagliflozin) has been linked with “ketoacidosis,” a serious condition that can lead to hospitalization, coma, and even death. The FDA recently released a drug safety communication warning healthcare providers to be on the watch for symptoms like nausea and…
In December 2014, the U.S. Judicial Panel on Multidistrict Litigation (JPML) centralized all federal Xarelto lawsuits into one court in the Eastern District of Louisiana. At the time, about 50 product liability lawsuits were pending in the court. That number has now increased to about…
On March 5, 2015, two parents from California filed a new Zofran lawsuit against drug manufacturers GlaxoSmithKline (GSK). They claim that Zofran is to blame for their son’s birth defects. Their case is pending in the Superior Court for the State of California, County of…
About a month ago, the Consumer Product Safety Commission (CPSC) announced that bicycle manufacturer Trek was recalling about a million bikes due to defective quick release levers, or “skewers,” as they’re sometimes called. When not properly adjusted, these levers can become lodged in the disc…
On April 10, 2015, Illinois resident James Boyle filed a new table saw lawsuit against Black & Decker, Inc. The plaintiff claims he was unnecessarily injured when working on his Black & Decker table saw, and seeks in excess of $75,000 in damages. The case…
The U.S. Judicial Panel on Multidistrict Litigation (JPML) established the Xarelto MDL on December 12, 2014. Since then, all federal cases have been transferred to the Eastern District of Louisiana for pre-trial proceedings. On May 4, 2015, the court released a case management order addressing…
A new Zofran lawsuit has been filed in Texas. The plaintiff, a resident of Texarkana, Texas, claims that the anti-nausea drug, which she took during her pregnancy, caused serious injuries to her child. She seeks in excess of $75,000 in damages from manufacturer GlaxoSmithKline (GSK).…
